Copyright © 2001 by the European Society of Cardiology.
Letter to the Editor
Lipoprotein (a) and thrombogenesis in left ventricular dysfunction
Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birimingham, U.K.
References
- Rehnqvist N. Cell adhesion molecules, simvastatin and hormone replacement therapy, in coronary artery disease. Eur Heart J. 2000;21:963964
[Free Full Text] - Scott J. Lipoprotein (a). Br Med J. 1991;303:663664
[Free Full Text] - Igarashi Y, Yamaura M, Ito M. Elevated serum lipoprotein (a) is a risk factor for left atrial thrombus in patients with chronic atrial fibrillation: A transesophageal echocardiographic study. Am Heart J. 1998;136:965971[CrossRef][Web of Science][Medline]
- Lip GYH, Gibbs CR. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol. 1999;33:14241426
[Free Full Text] - Sandholzer C, Boerwinkle E, Saha N, Tong MC, Utermann G. Apolipoprotein (a) phenotypes, Lp(a) concentrations and plasma lipid levels in relation to coronary artery disease in a Chinese population: evidence for the role of the apo(a) gene in coronary artery disease. J Clin Invest. 1992;89:10401046[Web of Science][Medline]
- Guyton JR, Dahlen GH, Patsch W, Kautz JA, Gotto AM. Relationship of plasma lipoprotein Lp(a) levels to race and apolipoprotein B. Arteriosclerosis. 1985;5:265271
[Abstract/Free Full Text] - Scanu AM. Lipoprotein (a). A genetic risk factor for premature coronary heart disease. JAMA. 1992;267:33263329
[Abstract/Free Full Text]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||